Technology-Enabled Balloon Catheters to Drive Market Growth to US$ 6.4 Billion by 2033 | FMI Report

The Balloon Catheter Market has experienced significant growth in recent years, driven by advancements in medical technology and the increasing prevalence of cardiovascular diseases. Balloon catheters are minimally invasive medical devices used for various diagnostic and therapeutic procedures, primarily within the cardiovascular field. These catheters consist of an inflatable balloon at the tip, which can be expanded or deflated to treat conditions such as coronary artery disease, peripheral artery disease, and valvular heart diseases.

The market growth is attributed to factors like the rising aging population, lifestyle changes leading to higher cardiovascular risks, and a growing demand for minimally invasive procedures. Balloon catheters offer benefits such as reduced patient recovery time, shorter hospital stays, and decreased procedural complications compared to traditional surgical methods. Moreover, technological advancements, such as improved balloon materials, enhanced imaging capabilities, and better catheter designs, have contributed to the increased adoption of these devices.

Empower your business with insights and knowledge from our Sample Report! https://www.futuremarketinsights.com/reports/sample/rep-gb-1916

The demand for balloon catheters around the world is expected to increase at a CAGR of 4.3%. The market revenue is anticipated to reach a value of US$ 4.2 billion in 2023 and to climb to US$ 6.4 billion by 2033.

Geographically, the market’s landscape is divided into regions such as North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America has historically held a significant share of the market due to a well-established healthcare infrastructure and high healthcare expenditure. However, the Asia Pacific region is witnessing rapid growth due to the increasing healthcare awareness, rising disposable income, and expanding access to medical facilities.

Key Takeaways from the Balloon Catheter Market:

• From 2023 to 2033, the United Kingdom market is likely to accelerate at a CAGR of 8% and reach a value of US$ 273.4 million in 2033.
• Germany market is also anticipated to expand at 7% CAGR and reach US$ 244.3 million in 2033.
• The global balloon catheter market is expected to register 4.3% CAGR between 2023 and 2033.
• A value of US$ 6.4 billion is estimated for the global balloon catheter market in the year 2033.
• The global balloon catheter market is poised to reach a valuation of US$ 4.2 billion in 2023.
• Rising prevalence of peripheral artery disease (PAD) is slated to fuel the need for balloon catheters in Europe.

“As peripheral artery disease is on rise in Europe, balloon catheter adoption is expected to skyrocket in the coming years. Key players are focusing on developing catheters that improve treatment outcomes.”– Says an FMI Analyst.

In Case Of Any Queries, Don’t Hesitate To Contact Our Analyst! https://www.futuremarketinsights.com/ask-question/rep-gb-1916

Competition Landscape in the Balloon Catheter Market:

To set themselves apart from their rivals in the industry and boost sales in the global balloon catheter market, manufacturing companies are concentrating on merger and acquisition strategies.

• Boston Scientific Inc.,
• Medtronic,
• Terumo Corporation,
• B. Braun Melsungen AG,
• MicroPort Scientific Corporation,
• Jotech GmbH,
• QX Medical LLC,
• Meril Life Pvt. Ltd.,
• Hexacath,
• Abbott Laboratories

Recent Developments:

• In October 2022, Biosense Webster, Inc., a Johnson & Johnson subsidy of medical technologies, revealed its European debut of a HELIOSTAR balloon catheter, the first radiofrequency balloon ablation catheter. It can be utilised for cardiac ablation when coupled with a suitable cross RF generator and catheter-based heart electrophysiological imaging of the atria.
• In July 2021, PrevailTM drug coated balloon (DCB) catheters were introduced in Europe under the CE (Conformité Européenne) standard by Medtronic plc, a leading company in medical technology. The Prevail DCB is used in percutaneous coronary intervention (PCI) treatments to treat blocked or restricted blood vessels in people with cardiovascular disease.

Get a Customized Scope to Match Your Need Ask an Expert! https://www.futuremarketinsights.com/customization-available/rep-gb-1916

Key Segments Profiled in the Balloon Catheter Market Survey

By Product Type:

• Normal
• Cutting
• Scoring
• Drug Eluting
• Others

By Raw Material:

• Polyurethane
• Nylon
• Others

By Indication:

• Coronary Artery Disease
• Peripheral Vascular Disease

By End User:

• Hospitals
• Ambulatory Surgical Centers
• Cardiac Catheterization Laboratories

By Region:

• North America
• Latin America
• Asia Pacific
• MEA
• Europe

Seize this Opportunity for Detailed Market Intel: Purchase Now to Access! https://www.futuremarketinsights.com/checkout/1342

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube